Interventional cytopathology and cancer in Peru: how to act during COVID-19?

The worldwide health crisis due to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) has affected all healthcare systems. Low- and middle-income countries have needed to establish health strategies to combat the pandemic, many of which have collaterally affected the diagnosis and treatmen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ecancermedicalscience 2020-12, Vol.14, p.1152-1152
Hauptverfasser: Abad-Licham, Milagros, Astigueta, Juan, Fernández, Caddie Laberiano, Torres, Himelda Chávez, Torres, Grisnery Maquera, Figueroa, Edwin, Bardales, Ricardo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1152
container_issue
container_start_page 1152
container_title Ecancermedicalscience
container_volume 14
creator Abad-Licham, Milagros
Astigueta, Juan
Fernández, Caddie Laberiano
Torres, Himelda Chávez
Torres, Grisnery Maquera
Figueroa, Edwin
Bardales, Ricardo
description The worldwide health crisis due to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) has affected all healthcare systems. Low- and middle-income countries have needed to establish health strategies to combat the pandemic, many of which have collaterally affected the diagnosis and treatment of other illnesses. One of these other illnesses is cancer, which in Peru represents the primary cause of mortality. In recent decades, interventional cytopathology with fine-needle biopsy techniques has emerged as a minimally invasive, rapid, economical and effective procedure for diagnosing and staging cancer. However, in the current health context, it is confronted by the challenge of continuing to function in spite of the pandemic. This article reviews the existing literature on interventional cytopathology, the risk of infection from SARS-CoV-2 and biosafety and provides recommendations for carrying out said procedures for the benefit of the patient and the safety of healthcare staff.
doi_str_mv 10.3332/ecancer.2020.1152
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7864686</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2489251245</sourcerecordid><originalsourceid>FETCH-LOGICAL-c351t-afc32119a8faad1fe850011f17f89c33f14dccb6bf372784b00f96294fcac6fa3</originalsourceid><addsrcrecordid>eNpVUc1PwjAUb4xGEP0DvJgevQz72rXbPGgMfpGQ4EG9Nl3Xwsxosdsw_PeOgARP7yXv95X3Q-gSyJAxRm-MVk6bMKSEkiEAp0eoDwmPIyEIPz7Ye-isrr8IEZBRfop6jPEkTrOkjyZj15iwMq4pvVMV1uvGL1Uz95WfrbFyBd564NLhNxPaWzz3P7jxWOkGF20o3QyPpp_jxwiy-3N0YlVVm4vdHKCP56f30Ws0mb6MRw-TSDMOTaSsZhQgU6lVqgBrUk4IgIXEpplmzEJcaJ2L3LKEJmmcE2IzQbPYaqWFVWyA7ra6yzZfmEJ36YOq5DKUCxXW0qtS_r-4ci5nfiWTVMQiFZ3A9U4g-O_W1I1clLU2VaWc8W0tafccyoHGvIPCFqqDr-tg7N4GiNy0IHctyE0LctNCx7k6zLdn_L2d_QILpoWy</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2489251245</pqid></control><display><type>article</type><title>Interventional cytopathology and cancer in Peru: how to act during COVID-19?</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Abad-Licham, Milagros ; Astigueta, Juan ; Fernández, Caddie Laberiano ; Torres, Himelda Chávez ; Torres, Grisnery Maquera ; Figueroa, Edwin ; Bardales, Ricardo</creator><creatorcontrib>Abad-Licham, Milagros ; Astigueta, Juan ; Fernández, Caddie Laberiano ; Torres, Himelda Chávez ; Torres, Grisnery Maquera ; Figueroa, Edwin ; Bardales, Ricardo</creatorcontrib><description>The worldwide health crisis due to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) has affected all healthcare systems. Low- and middle-income countries have needed to establish health strategies to combat the pandemic, many of which have collaterally affected the diagnosis and treatment of other illnesses. One of these other illnesses is cancer, which in Peru represents the primary cause of mortality. In recent decades, interventional cytopathology with fine-needle biopsy techniques has emerged as a minimally invasive, rapid, economical and effective procedure for diagnosing and staging cancer. However, in the current health context, it is confronted by the challenge of continuing to function in spite of the pandemic. This article reviews the existing literature on interventional cytopathology, the risk of infection from SARS-CoV-2 and biosafety and provides recommendations for carrying out said procedures for the benefit of the patient and the safety of healthcare staff.</description><identifier>ISSN: 1754-6605</identifier><identifier>EISSN: 1754-6605</identifier><identifier>DOI: 10.3332/ecancer.2020.1152</identifier><identifier>PMID: 33574897</identifier><language>eng</language><publisher>England: Cancer Intelligence</publisher><subject>Short Communication</subject><ispartof>Ecancermedicalscience, 2020-12, Vol.14, p.1152-1152</ispartof><rights>the authors; licensee ecancermedicalscience.</rights><rights>the authors; licensee cancermedicalscience. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864686/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864686/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33574897$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abad-Licham, Milagros</creatorcontrib><creatorcontrib>Astigueta, Juan</creatorcontrib><creatorcontrib>Fernández, Caddie Laberiano</creatorcontrib><creatorcontrib>Torres, Himelda Chávez</creatorcontrib><creatorcontrib>Torres, Grisnery Maquera</creatorcontrib><creatorcontrib>Figueroa, Edwin</creatorcontrib><creatorcontrib>Bardales, Ricardo</creatorcontrib><title>Interventional cytopathology and cancer in Peru: how to act during COVID-19?</title><title>Ecancermedicalscience</title><addtitle>Ecancermedicalscience</addtitle><description>The worldwide health crisis due to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) has affected all healthcare systems. Low- and middle-income countries have needed to establish health strategies to combat the pandemic, many of which have collaterally affected the diagnosis and treatment of other illnesses. One of these other illnesses is cancer, which in Peru represents the primary cause of mortality. In recent decades, interventional cytopathology with fine-needle biopsy techniques has emerged as a minimally invasive, rapid, economical and effective procedure for diagnosing and staging cancer. However, in the current health context, it is confronted by the challenge of continuing to function in spite of the pandemic. This article reviews the existing literature on interventional cytopathology, the risk of infection from SARS-CoV-2 and biosafety and provides recommendations for carrying out said procedures for the benefit of the patient and the safety of healthcare staff.</description><subject>Short Communication</subject><issn>1754-6605</issn><issn>1754-6605</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpVUc1PwjAUb4xGEP0DvJgevQz72rXbPGgMfpGQ4EG9Nl3Xwsxosdsw_PeOgARP7yXv95X3Q-gSyJAxRm-MVk6bMKSEkiEAp0eoDwmPIyEIPz7Ye-isrr8IEZBRfop6jPEkTrOkjyZj15iwMq4pvVMV1uvGL1Uz95WfrbFyBd564NLhNxPaWzz3P7jxWOkGF20o3QyPpp_jxwiy-3N0YlVVm4vdHKCP56f30Ws0mb6MRw-TSDMOTaSsZhQgU6lVqgBrUk4IgIXEpplmzEJcaJ2L3LKEJmmcE2IzQbPYaqWFVWyA7ra6yzZfmEJ36YOq5DKUCxXW0qtS_r-4ci5nfiWTVMQiFZ3A9U4g-O_W1I1clLU2VaWc8W0tafccyoHGvIPCFqqDr-tg7N4GiNy0IHctyE0LctNCx7k6zLdn_L2d_QILpoWy</recordid><startdate>20201207</startdate><enddate>20201207</enddate><creator>Abad-Licham, Milagros</creator><creator>Astigueta, Juan</creator><creator>Fernández, Caddie Laberiano</creator><creator>Torres, Himelda Chávez</creator><creator>Torres, Grisnery Maquera</creator><creator>Figueroa, Edwin</creator><creator>Bardales, Ricardo</creator><general>Cancer Intelligence</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20201207</creationdate><title>Interventional cytopathology and cancer in Peru: how to act during COVID-19?</title><author>Abad-Licham, Milagros ; Astigueta, Juan ; Fernández, Caddie Laberiano ; Torres, Himelda Chávez ; Torres, Grisnery Maquera ; Figueroa, Edwin ; Bardales, Ricardo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c351t-afc32119a8faad1fe850011f17f89c33f14dccb6bf372784b00f96294fcac6fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Short Communication</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abad-Licham, Milagros</creatorcontrib><creatorcontrib>Astigueta, Juan</creatorcontrib><creatorcontrib>Fernández, Caddie Laberiano</creatorcontrib><creatorcontrib>Torres, Himelda Chávez</creatorcontrib><creatorcontrib>Torres, Grisnery Maquera</creatorcontrib><creatorcontrib>Figueroa, Edwin</creatorcontrib><creatorcontrib>Bardales, Ricardo</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Ecancermedicalscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abad-Licham, Milagros</au><au>Astigueta, Juan</au><au>Fernández, Caddie Laberiano</au><au>Torres, Himelda Chávez</au><au>Torres, Grisnery Maquera</au><au>Figueroa, Edwin</au><au>Bardales, Ricardo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interventional cytopathology and cancer in Peru: how to act during COVID-19?</atitle><jtitle>Ecancermedicalscience</jtitle><addtitle>Ecancermedicalscience</addtitle><date>2020-12-07</date><risdate>2020</risdate><volume>14</volume><spage>1152</spage><epage>1152</epage><pages>1152-1152</pages><issn>1754-6605</issn><eissn>1754-6605</eissn><abstract>The worldwide health crisis due to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) has affected all healthcare systems. Low- and middle-income countries have needed to establish health strategies to combat the pandemic, many of which have collaterally affected the diagnosis and treatment of other illnesses. One of these other illnesses is cancer, which in Peru represents the primary cause of mortality. In recent decades, interventional cytopathology with fine-needle biopsy techniques has emerged as a minimally invasive, rapid, economical and effective procedure for diagnosing and staging cancer. However, in the current health context, it is confronted by the challenge of continuing to function in spite of the pandemic. This article reviews the existing literature on interventional cytopathology, the risk of infection from SARS-CoV-2 and biosafety and provides recommendations for carrying out said procedures for the benefit of the patient and the safety of healthcare staff.</abstract><cop>England</cop><pub>Cancer Intelligence</pub><pmid>33574897</pmid><doi>10.3332/ecancer.2020.1152</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1754-6605
ispartof Ecancermedicalscience, 2020-12, Vol.14, p.1152-1152
issn 1754-6605
1754-6605
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7864686
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access
subjects Short Communication
title Interventional cytopathology and cancer in Peru: how to act during COVID-19?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T01%3A51%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interventional%20cytopathology%20and%20cancer%20in%20Peru:%20how%20to%20act%20during%20COVID-19?&rft.jtitle=Ecancermedicalscience&rft.au=Abad-Licham,%20Milagros&rft.date=2020-12-07&rft.volume=14&rft.spage=1152&rft.epage=1152&rft.pages=1152-1152&rft.issn=1754-6605&rft.eissn=1754-6605&rft_id=info:doi/10.3332/ecancer.2020.1152&rft_dat=%3Cproquest_pubme%3E2489251245%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2489251245&rft_id=info:pmid/33574897&rfr_iscdi=true